Masao Kobayashi1, Shiho Nishimura1, Maiko Shimomura1, Shinobu Sasaki1, Naoya Yamasaki2, Teruhisa Fujii2 (1.Department of Pediatrics, Hiroshima University Hospital, Hiroshima, Japan, 2.Division of blood transfusion)
Session information
Oral Session
Oral Session 2-13C Hemophilia
Sat. Oct 13, 2018 2:50 PM - 3:50 PM No.13 (Osaka International Convention Center, 11F 1101-2)
Chair: Kagehiro Amano (Department of Laboratory Medicine, Tokyo Medical University, Japan)
Shinobu Tatsunami1, Kagehiro Amano2, Akira Shirahata3, Masashi Taki4 (1.Unit of Medical Informatics, St. Marianna University, Kawasaki, Japan, 2.Department of Laboratory Medicine, Tokyo Medical University Hospital, Japan, 3.Kitakyushu Yahata-higashi Hospital, Kitakyushu, Japan, 4.Department of Pediatrics, St. Marianna University Seibu Hospital, Yokohama, Japan)
Kiyotaka Isobe, Jun Noguchi, Masahiro Sugawa, Nasato Yanagi, Makiko Mori, Yuki Arakawa, Katsuyoshi Koh (Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan)
Hiroki Horiuchi1, Kenichi Ogiwara1, Keiji Nogami1, Takehisa Kitazawa2, Midori Shima1 (1.Pediatrics, Nara Medical University, Nara, Japan, 2.Research Division, Chugai Pharmaceutical Co., Ltd,)
Midori Shima1, Johnny Mahlangu2, Johannes Oldenburg3, Takashi Suzuki4, Yasuharu Nishida5, Tadashi Matsushita6, Toshihiro Ito7, Masashi Taki8, Katsuyuki Fukutake9, Ido Paz-Priel10, Claude Negrier11, Markus Niggli12, Maria Elisa Mancuso13, Christophe Schmitt12, Victor Jime'Nez-Yuste14, Christine Kempton15, Christophe Dhalluin12, Michael Callaghan16, Willem Bujan17, Joanne I. Adamkewicz10, Elina Asikanius12, Sayaka Nagami18, Wataru Ohtsuka18, Koichiro Yoneyama18, Ryu Kasai18, Gallia G. Levy10, Rebecca Kruse-Jarres19 (1.Pediatrics, Nara Med Univ., Kashihara, Japan, 2.University of the Witwatersrand and NHLS, Johannesburg, South Africa, 3.Universitaetsklinikum Bonn, Bonn, Germany, 4.Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan, 5.Division of Infectious Disease, NHO Osaka National Hospital, Osaka, Japan, 6.Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan, 7.Dep. of infect. dis., NHO Sendai National Hospital, Sendai, Japan, 8.Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan, 9.Labo-Med., Tokyo Med., Univ., Tokyo, Japan, 10.Genentech Inc, South San Francisco, California, USA, 11.Louis Pradel University Hospital, Lyon, France, 12.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 13.Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy, 14.Hematology Department, Hospital Universitario La Paz, Auto'noma University, Madrid, Spain, 15.Emory School of Medicine, Atlanta, USA, 16.Children's Hospital of Michigan, Detroit, MI, USA, 17.Instituto Costarricense de Investigaciones Cienti'ficas, San Jose', Costa Rica, 18.Chugai Pharmaceutical co., ltd., Tokyo, Japan, 19.Washington Center for Bleeding Disorders, Seattle, WA, USA)
Katsuyuki Fukutake1, Steven Pipe2, Victor Jimenez-Yuste3, Akira Ishiguro4, Takanori Teshima5, Amy Shapiro6, Nigel Key7, Maria Podolak-Dawidziak8, Cedric Hermans9, Peerlinck Kathelijne10, Michaela Lehle11, Sammy Chebon11, Agnes Portron11, Nives Selak Bienz11, Sayaka Nagami12, Wataru Ohtsuka12, Koichiro Yoneyama12, Ryu Kasai12, Gallia G. Levy13, Midori Shima14 (1.Labo-Med., Tokyo Med., Univ., Tokyo, Japan, 2.University of Michigan, C.S. Mott Children's Hospital, Ann Arbor, USA, 3.Hospital Universitario La Paz, Auto'noma University, Madrid, Spain, 4.Division of Hematol, NCCHD, Tokyo, Japan, 5.Hematol., Hokkaido Univ., Tokyo, Japan, 6.Indiana Hemophilia and Thrombosis Center, Indianapolis, USA, 7.University of N Carolina, Chapel Hill, North Carolina, USA, 8.Medical University Department of Hematology, Wroclaw, Poland, 9.UZ Leuven Gasthuisberg, Leuven, Belgium, 10.Cliniques Universitaires St-Luc, Brussels, Belgium, 11.F. Hoffmann-La Roche Ltd, Basel, Switzerland, 12.Chugai Pharmaceutical co., ltd., Tokyo, Japan, 13.Genentech Inc., South San Francisco; USA, 14.Pediatrics, Nara Med Univ. Kashihara, Japan)